Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
DCP-001
print preview
bookmark
share with colleague
General Information
Company
DCPrime B.V.
Description
Off-the-shelf dendritic cell vaccine based on DCOne technology
Molecular Target
Not applicable
Mechanism of Action
Vaccine
Latest Stage of Development
Phase I/II
Indication
Acute myelogenous leukemia (AML)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy